COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

UC San Diego Physician-Scientist Wins National Honor for Pediatric Research

 

May 08, 2008  |  

Victor Nizet, M.D., a professor of pediatrics and pharmacy at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, and physician at the Rady Children’s Hospital San Diego, has been selected as the 2008 recipient of the most prestigious award in pediatric research by the Pediatric Academic Societies. 

 

Victor Nizet

Victor Nizet, M.D., recipient of the E. Mead Johnson Award


Nizet was presented the E. Mead Johnson Award for Research in Pediatrics at the Societies’ annual meeting in Honolulu for his work deciphering the disease-producing mechanisms of common childhood bacterial pathogens, and for increasing understanding of immune system function. Established in 1939, the award recognizes outstanding laboratory or clinical research achievements benefiting children.  During his career at UC San Diego, Nizet's laboratory has explored the complex processes by which bacteria such as Streptococcus ("strep") and Staphylococcus ("staph") can survive and spread in the human host to produce serious infections such as sepsis and meningitis.  

 

“For the past decade, Victor Nizet has embarked on an effort to shed light on the interactions between the host and the pathogens, such as bacteria that commonly infect children,” said Gabriel G. Haddad, M.D., professor of pediatrics and neurosciences, chair of UCSD’s department of pediatrics and physician-in-chief at Rady’s Children’s Hospital.  “His work has resulted in  major progress in our understanding of how innate immunity functions and how to improve it to fight invading bacteria, perhaps allowing us to devise more or better therapeutic agents to kill invading pathogens in children.”

"I am deeply honored to be chosen as a recipient of the E. Mead Johnson Award which, in fact, directly recognizes the ingenuity of several talented graduate and postdoctoral trainees who have spearheaded the projects, as well as the outstanding commitment of UC San Diego to supporting leading edge medical research and collaboration,” said Nizet.

Nizet was recently appointed Chief of a new Division of Pharmacology and Drug Discovery, jointly sponsored by the Department of Pediatrics and the Skaggs School of Pharmacy and Pharmaceutical Sciences.  This new program seeks to establish a pathway for drug development, from initial discovery of novel compounds and targets to early stage clinical trials, with a major focus on development of new anti-infective strategies.

Nizet's previous honors include the Sidney Farber Award, the Pediatric Infectious Diseases Society Young Investigator Award, the Edward Mallinckrodt, Jr. Foundation Scholar Award, the American Heart Association Established Investigator Award, the American Lung Association Career Investigator Award, and election to the Society for Pediatric Research, the American Pediatric Society, and the American Society for Clinical Investigation.

For more information on his research, go to: http://nizetlab.ucsd.edu

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Share This Article


Related News

9/10/2021
UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Instit ...
9/9/2021
UC San Diego School of Medicine researchers will receive $6.4 million in National Institutes of Health grant funding to study how external signals and genetic variations influence the behavior of one ...
9/8/2021
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-bre ...
9/7/2021
UC San Diego Health improved care for more than 32,000 Medicare beneficiaries in San Diego, Riverside, and Imperial Counties, and saved Medicare close to $7 million by utilizing population health tech ...



Follow Us